24/7 Wall St. on MSN
Biotech could be one of 2026’s biggest winners, and this ETF is perfectly positioned
Quick Read FBT returned 29% over the past year and gained 5.4% in the first week of 2026. Federal Reserve officials forecast ...
According to ArkeoNews, the structure was built during a flourishing period of Roman expansion when thermal baths served not merely as places for hygiene, but as centers of healing and social ...
China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...
After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...
Reconstructed ancient enzymes reveal how cannabis evolved specialized cannabinoid production while offering new tools for biotechnology and medicine. Where do familiar cannabis compounds such as THC, ...
The Dubai Genome Program sequenced almost one million UAE citizens’ genomes by mid-2024. One million. That’s a ...
The 11th Global Startup Awards nominates BEP acknowledging its commitment to building life-science companies with ...
Most Americans likely will not benefit immediately from efforts to lower prescription prices. Administration officials expect ...
Evercrisp Biosciences, Inc., a portfolio company of Apple Tree Partners, entered bankruptcy within a month of a filing by another ATP-backed Red Queen Therapeutics.
Today, Senators Chuck Schumer and Kirsten Gillibrand announced they secured $5 million in federal funding for critical North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results